Benchmark Dose Analysis of DNA Damage Biomarker Responses Provides Compound Potency and Adverse Outcome Pathway Information for the Topoisomerase II Inhibitor Class of Compounds
Year: 2020
Type: article
DOI: 10.1002/em.22360
Institutions: Swansea University, Litron Laboratories (United States)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: Research and Development
OpenAlex ID: W3003124787
